0001225208-20-003299.txt : 20200224 0001225208-20-003299.hdr.sgml : 20200224 20200224171504 ACCESSION NUMBER: 0001225208-20-003299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200221 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scanlon Meghan CENTRAL INDEX KEY: 0001801586 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 20645481 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2020-02-21 0000885725 BOSTON SCIENTIFIC CORP BSX 0001801586 Scanlon Meghan 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP,Pres,Urology Pelvic Health Common Stock 2020-02-21 4 M 0 778.0000 0.0000 A 8099.0000 D Common Stock 2020-02-21 4 F 0 264.0000 42.6200 D 7835.0000 D Common Stock 2020-02-22 4 M 0 1159.0000 0.0000 A 8994.0000 D Common Stock 2020-02-22 4 F 0 331.0000 42.6200 D 8663.0000 D Common Stock 2020-02-23 4 M 0 1227.0000 0.0000 A 9890.0000 D Common Stock 2020-02-23 4 F 0 359.0000 42.6200 D 9531.0000 D Deferred Stock Units 2020-02-21 4 M 0 778.0000 0.0000 D 2023-02-21 Common Stock 778.0000 2337.0000 D Deferred Stock Units 2020-02-22 4 M 0 1159.0000 0.0000 D 2021-02-22 Common Stock 1159.0000 1159.0000 D Deferred Stock Units 2020-02-23 4 M 0 1227.0000 0.0000 D 2020-02-23 Common Stock 1227.0000 0.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. /s/ Scott G. Hodgdon, Attorney-in-Fact 2020-02-24